Skip to content

IGC PHARMA, INC.: 10-Q filed 2018-02-20

What IGC PHARMA, INC. reported in its quarterly report filed 2018-02-20 (fiscal Q3 2018): 41 published measures, 111 facts as tagged in accession 0001185185-18-000276.

This filing

Form
10-Q (quarterly report)
Filed
2018-02-20
Fiscal period
fiscal Q3 2018
Accession
0001185185-18-000276 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All IGC PHARMA, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2017-12-3111,336,145USD
At 2017-03-3111,284,302USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2017-12-313,861,280USD
At 2017-03-313,934,017USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2017-12-317,483,872USD
At 2017-03-317,359,121USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2017-12-311,690,792USD
At 2017-03-31538,029USD
At 2016-12-31744,055USD
At 2016-03-311,490,693USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2017-10-01 to 2017-12-31-532,581USD92
2017-04-01 to 2017-12-31-1,210,991USD275
2016-10-01 to 2016-12-31-111,561USD92
2016-04-01 to 2016-12-31-1,109,601USD275

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2017-04-01 to 2017-12-31-973,336USD275
2016-04-01 to 2016-12-31-483,068USD275

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2017-04-01 to 2017-12-3111,224USD275
2016-04-01 to 2016-12-31128,765USD275

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2017-10-01 to 2017-12-31762,009USD92
2017-04-01 to 2017-12-311,050,582USD275
2016-10-01 to 2016-12-31249,801USD92
2016-04-01 to 2016-12-31487,364USD275

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2017-04-01 to 2017-12-312,418,016USD275
2016-04-01 to 2016-12-31-121,010USD275

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2017-04-01 to 2017-12-31-301,497USD275
2016-04-01 to 2016-12-31-270,694USD275

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2017-12-31-53,219,180USD
At 2017-03-31-52,009,459USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2017-10-01 to 2017-12-3128,169,292shares92
2017-04-01 to 2017-12-3127,126,208shares275
2016-10-01 to 2016-12-3127,446,095shares92
2016-04-01 to 2016-12-3127,446,095shares275

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2017-10-01 to 2017-12-3128,169,292shares92
2017-04-01 to 2017-12-3127,126,208shares275
2016-10-01 to 2016-12-3127,446,095shares92
2016-04-01 to 2016-12-3127,446,095shares275

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2017-10-01 to 2017-12-31-0.02USD/shares92
2017-04-01 to 2017-12-31-0.04USD/shares275
2016-10-01 to 2016-12-310USD/shares92
2016-04-01 to 2016-12-31-0.04USD/shares275

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2017-10-01 to 2017-12-31-0.02USD/shares92
2017-04-01 to 2017-12-31-0.04USD/shares275
2016-10-01 to 2016-12-310USD/shares92
2016-04-01 to 2016-12-31-0.04USD/shares275

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2017-10-01 to 2017-12-310USD92
2016-10-01 to 2016-12-310USD92

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2017-12-31951,351USD
At 2017-03-31953,936USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2017-04-01 to 2017-12-31426,111USD275
2016-04-01 to 2016-12-310USD275

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2017-10-01 to 2017-12-31-473,374USD92
2017-04-01 to 2017-12-31-1,075,121USD275
2016-10-01 to 2016-12-31-386,112USD92
2016-04-01 to 2016-12-31-1,319,289USD275

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2017-12-313,225,806USD
At 2017-03-313,581,363USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2017-10-01 to 2017-12-3160,527USD92
2017-04-01 to 2017-12-31145,905USD275
2016-10-01 to 2016-12-3146,465USD92
2016-04-01 to 2016-12-31136,421USD275

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2017-12-311,324,183USD
At 2017-03-311,289,711USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2017-12-31198,169USD
At 2017-03-31198,169USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2017-12-311,155,229USD
At 2017-03-31752,926USD

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2017-10-01 to 2017-12-31723,062USD92
2017-04-01 to 2017-12-31893,113USD275
2016-10-01 to 2016-12-31121,829USD92
2016-04-01 to 2016-12-31276,418USD275

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2017-10-01 to 2017-12-31507,332USD92
2017-04-01 to 2017-12-311,217,293USD275
2016-10-01 to 2016-12-31322,891USD92
2016-04-01 to 2016-12-31959,693USD275

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2017-12-3129,499,790shares
At 2017-03-3128,272,667shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2017-12-3162,737,631USD
At 2017-03-3161,413,533USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2017-12-31-2,037,529USD
At 2017-03-31-2,047,780USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2017-12-317,474,865USD
At 2017-03-317,350,285USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2017-12-313,602,459USD
At 2017-03-313,549,125USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2017-12-312,651,108USD
At 2017-03-312,595,189USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2017-12-31124,272USD
At 2017-03-310USD
At 2016-03-31113,321USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2017-12-31820,913USD
At 2017-03-31539,720USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2017-12-31175,200USD
At 2017-03-31181,465USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2017-12-31379,785USD
At 2017-03-31410,408USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2017-10-01 to 2017-12-31-532,811USD92
2017-04-01 to 2017-12-31-1,211,625USD275
2016-10-01 to 2016-12-31-73,473USD92
2016-04-01 to 2016-12-31-1,082,753USD275

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2017-10-01 to 2017-12-314,989USD92
2017-04-01 to 2017-12-3115,297USD275
2016-10-01 to 2016-12-31196,103USD92
2016-04-01 to 2016-12-31391,617USD275

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2017-10-01 to 2017-12-311,090USD92
2017-04-01 to 2017-12-319,401USD275
2016-10-01 to 2016-12-31359,104USD92
2016-04-01 to 2016-12-31372,957USD275

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2017-04-01 to 2017-12-312,636,478USD275
2016-04-01 to 2016-12-31438,165USD275

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2017-04-01 to 2017-12-31401,811USD275
2016-04-01 to 2016-12-31-299,848USD275

Inspect the source

Entity
IGC PHARMA, INC. / CIK 0001326205
Captured
2026-09-19T11:17:33.392Z
SEC response SHA-256
b5e6159ba110e204ee8261b531c546158153a9053fcdb3ca873d1eff8c2a793e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001326205.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))